Accrued expenses and other current liabilities - Value Added Tax (Details) - 1 months ended Jun. 30, 2014 £ in Millions, $ in Millions |
GBP (£) |
USD ($) |
|---|---|---|
| GlaxoSmithKline Intellectual Property Development Ltd | Collaborative arrangement | ||
| Collaboration and License Agreement | ||
| Upfront payment received | £ 25 | $ 42.1 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Cash received from licensees for license fees during the current period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|